APO Research, Inc.

Find your market.

Compare the product scope, applications and research editions relevant to your next decision.

Our research approach
Browse the complete product directory →

9,053 topics, 45,265 reports

Clear all filters

Pharma & Healthcare

Deferasirox

Deferasirox is an oral iron chelator. Its main use is to reduce chronic iron overload in patients who are receiving long-term blood transfusions for conditions such as beta- thalassemia and other chronic anemias.

Types
500 mg/Tablet · 250 mg/Tablet · 125 mg/Tablet
Applications
Transfusional Iron Overload · NTDT Caused Iron Overload

5 editions25 December 2025

View 5 research editions
APO Research, Inc.